Cryo-Cell International logo
Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
3.650
-0.500 (-12.05%)
Oct 15, 2026, 4:00 PM EDT - Market closed

Cryo-Cell International Cash Flow Statement

Millions USD. Fiscal year is Dec - Nov.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Net Income
-1.95-2.430.4-9.522.772.08
Depreciation & Amortization
1.351.371.021.711.811.33
Other Amortization
0.020.020.020.020.020.06
Loss (Gain) From Sale of Assets
-0.05---0.410.02
Asset Writedown & Restructuring Costs
---13.11--
Loss (Gain) From Sale of Investments
0.30.81-0.87-0.170.040.01
Stock-Based Compensation
0.360.420.780.820.460.3
Provision & Write-off of Bad Debts
1.010.871.271.040.930.54
Other Operating Activities
1.541.54-0.31-4.06-1.3-1.26
Change in Accounts Receivable
-1.01-0.41-2-1.57-1.720.53
Change in Inventory
-0.070.060.430.360.490.21
Change in Accounts Payable
-0.191-0.420.690.120.53
Change in Unearned Revenue
4.394.365.455.34.954.25
Change in Other Net Operating Assets
-0.83-2.170.241.20.41-0.67
Operating Cash Flow
4.925.486.018.928.577.93
Operating Cash Flow Growth
-22.57%-8.86%-32.61%4.05%8.16%-6.38%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Capital Expenditures
-0.27-0.23-2.4-6.84-12.17-1.83
Sale of Property, Plant & Equipment
-0.12--1.87-
Sale (Purchase) of Intangibles
---1.2-0.8-5-5.12
Investment in Securities
-0.15-0.86-1.27-0.510.02-
Investing Cash Flow
-0.42-0.98-4.88-8.14-15.28-6.95

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Short-Term Debt Issued
-8.85.220.957.67-
Long-Term Debt Issued
----8.96-
Total Debt Issued
3.28.85.220.9516.63-
Short-Term Debt Repaid
--10.02-2.92-2-5.4-
Long-Term Debt Repaid
--0.15-0.14-0.16-1.95-4.1
Total Debt Repaid
-6.57-10.17-3.06-2.16-7.35-4.1
Net Debt Issued (Repaid)
-3.37-1.372.16-1.219.29-4.1
Issuance of Common Stock
0.020.020.08-0.551.28
Repurchase of Common Stock
--0.17-1.42-0.8-1.82-0.25
Common Dividends Paid
--3.23-2.02---
Other Financing Activities
--0.23-0.07-0.2-
Financing Cash Flow
-3.34-4.75-0.98-2.070.15-3.07

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Net Cash Flow
1.16-0.240.15-1.3-6.56-2.1

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Free Cash Flow
4.655.253.612.08-3.66.09
Free Cash Flow Growth
-24.77%45.49%73.36%---27.19%
Free Cash Flow Margin
14.94%16.63%11.28%6.64%-11.85%21.09%
Free Cash Flow Per Share
0.580.650.440.25-0.420.73
Levered Free Cash Flow
-0.070.58-3.05-3.99-15.312.38
Unlevered Free Cash Flow
1.051.85-1.91-3.24-14.663.19

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Cash Interest Paid
1.832.031.981.811.261.04
Cash Income Tax Paid
3.164.592.721.821.573.53
Change in Working Capital
2.282.843.75.994.254.86
SEC Filings: 10-K · 10-Q